ADIPOQ and metabolic syndrome: Although in menopause its serum levels may be reduced in obese women and in women affected by insulin resistance and metabolic syndrome [19–21], there are actually no studies evaluating in menopausal women the possible links of serum adiponectin levels and cognitive performance.